🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
It is our hypothesis that a course of Ta1 administered to hospitalized indi...
Status
Terminated
Location
The Miriam Hospital
Start Date
2020-09-10
Trial ID
NCT04487444
Treatments Being Tested
Thymalfasin (thymosin alpha 1 or Ta1), the active pharmaceutical ingredient...
Status
Completed
Location
Clinical Research Consultants
Start Date
2021-01-12
Trial ID
NCT04428008
Treatments Being Tested
The purpose of this study is to determine whether thymalfasin is safe and e...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2016-09-06
Trial ID
NCT02867267
Treatments Being Tested
Thymosin alpha 1 plus maintenance therapy with the Standard of Care (SoC) c...
Status
Unknown
Location
Azienda Sanitaria Locale Frosinone
Start Date
2016-09
Trial ID
NCT02906150
Treatments Being Tested
Phase I: evaluate the safety and tolerability two different dosing regimens...
Status
Unknown
Location
Azienda Sanitaria Locale Frosinone
Start Date
2016-10
Trial ID
NCT02906163
Treatments Being Tested
This is a multicenter, open-label, prospective, randomized controlled Phase...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2025-02-11
Trial ID
NCT06829355
Treatments Being Tested
The goal of this research is to learn more about ZADAXIN® (trade name; thym...
Status
Recruiting
Location
Houston Methodist Hospital
Start Date
2024-12-02
Trial ID
NCT06821100
Treatments Being Tested